1,392
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Long non-coding RNA LINC00473 promotes glioma cells proliferation and invasion by impairing miR-637/CDK6 axis

, , , &
Pages 3896-3903 | Received 20 Jun 2019, Accepted 16 Aug 2019, Published online: 27 Sep 2019

References

  • Schwartzbaum JA, Fisher JL, Aldape KD, et al. Epidemiology and molecular pathology of glioma. Nat Rev Neurol. 2006;2(9):494.
  • McNeill KA. Epidemiology of brain tumors. Neurol Clin. 2016;34(4):981–998.
  • Morgan LL. The epidemiology of glioma in adults: a “state of the science” review. Neuro-oncology, 2015;17(4):623–624.
  • Feng X, Yu Y, He S, et al. Dying glioma cells establish a proangiogenic microenvironment through a caspase 3 dependent mechanism. Cancer Lett. 2017;385:12–20.
  • Hanif F, Muzaffar K, Perveen K, et al. Glioblastoma multiforme: a review of its epidemiology and pathogenesis through clinical presentation and treatment. Asian Pac J Cancer Prev. 2017;18(1):3.
  • Feinberg AP, Koldobskiy MA, Göndör A. Epigenetic modulators, modifiers and mediators in cancer aetiology and progression. Nat Rev Genet. 2016;17(5):284.
  • Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10(3):155.
  • Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer. 2011;10(1):38.
  • Calle AS, Kawamura Y, Yamamoto Y, et al. Emerging roles of long non‐coding RNA in cancer. Cancer Sci. 2018;109(7):2093.
  • Zhang H, Yang F, Chen S J, et al. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma. Tumor Biol. 2015;36(4):2947–2955.
  • Liu H, Zhen Q, Fan Y. LncRNA GHET1 promotes esophageal squamous cell carcinoma cells proliferation and invasion via induction of EMT. Int J Biol Markers. 2017;32(4):403–408.
  • Zhang G, An X, Zhao H, et al. Long non-coding RNA HNF1A-AS1 promotes cell proliferation and invasion via regulating miR-17-5p in non-small cell lung cancer. Biomed Pharmacother. 2018;98:594–599.
  • Chen Z, Li JL, Lin S, et al. cAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growth.J Clin Invest. 2016;126(6):2267–2279.
  • Zhu S, Fu W, Zhang L, et al. LINC 00473 antagonizes the tumour suppressor miR‐195 to mediate the pathogenesis of Wilms tumour via IKKα. Cell Prolif. 2018;51(1):e12416.
  • Shi C, Yang Y, Yu J, et al. The long noncoding RNA LINC00473, a target of microRNA 34a, promotes tumorigenesis by inhibiting ILF2 degradation in cervical cancer. Am J Cancer Res. 2017;7(11):2157.
  • Thomson D W, Dinger M E. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet. 2016;17(5):272.
  • Ambros V. The functions of animal microRNAs. Nature. 2004;431(7006):350.
  • Chaichana KL, McGirt MJ, Laterra J, et al. Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas. J Neurosurg. 2010;112(1):10–17.
  • Gong X, Liao X, Huang M. LncRNA CASC7 inhibits the progression of glioma via regulating Wnt/β-catenin signaling pathway. Pathol-Res Pract. 2019;215:564–570.
  • Xu D H, Chi G N, Zhao C H, et al. Long noncoding RNA MEG3 inhibits proliferation and migration but induces autophagy by regulation of Sirt7 and PI3K/AKT/mTOR pathway in glioma cells. J Cell Biochem. 2018. [Epub ahead of print].
  • Shen F, Chang H, Gao G, et al. Long noncoding RNA FOXD2‐AS1 promotes glioma malignancy and tumorigenesis via targeting miR‐185‐5p/CCND2 axis. J Cell Biochem. 2019;120:9324–9336.
  • Qin N, Tong GF, Sun LW, et al. Long noncoding RNA MEG3 suppresses glioma cell proliferation, migration, and invasion by acting as a competing endogenous RNA of miR-19a. Oncol Res. 2017;25(9):1471–1478.
  • Liu L, Cui S, Wan T, et al. Long non‐coding RNA HOTAIR acts as a competing endogenous RNA to promote glioma progression by sponging miR‐126‐5p. J Cell Physiol. 2018;233(9):6822–6831.
  • Chen Y, Zhao F, Cui D, et al. HOXD‐AS1/miR‐130a sponge regulates glioma development by targeting E2F8. Int J Cancer. 2018;142(11):2313–2322.
  • Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999;13(12):1501–1512.
  • Deng M, Zeng C, Lu X, et al. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop. Cancer Lett. 2017;403:175–185.
  • Lu YB, Jiang Q, Yang MY, et al. Long noncoding RNA NNT-AS1 promotes hepatocellular carcinoma progression and metastasis through miR-363/CDK6 axis. Oncotarget. 2017;8(51):88804.